GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intelgenx Technologies Corp (FRA:0IL) » Definitions » EV-to-FCF

Intelgenx Technologies (FRA:0IL) EV-to-FCF : -6.21 (As of May. 26, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Intelgenx Technologies EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Intelgenx Technologies's Enterprise Value is €41.48 Mil. Intelgenx Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was €-6.68 Mil. Therefore, Intelgenx Technologies's EV-to-FCF for today is -6.21.

The historical rank and industry rank for Intelgenx Technologies's EV-to-FCF or its related term are showing as below:

FRA:0IL' s EV-to-FCF Range Over the Past 10 Years
Min: -93.34   Med: -7.11   Max: 14001.06
Current: -6.21

During the past 13 years, the highest EV-to-FCF of Intelgenx Technologies was 14001.06. The lowest was -93.34. And the median was -7.11.

FRA:0IL's EV-to-FCF is ranked worse than
100% of 372 companies
in the Biotechnology industry
Industry Median: 8.36 vs FRA:0IL: -6.21

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-26), Intelgenx Technologies's stock price is €0.143. Intelgenx Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.054. Therefore, Intelgenx Technologies's PE Ratio for today is At Loss.


Intelgenx Technologies EV-to-FCF Historical Data

The historical data trend for Intelgenx Technologies's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intelgenx Technologies EV-to-FCF Chart

Intelgenx Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.85 -5.47 -7.78 -4.34 -5.57

Intelgenx Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.27 -4.87 -4.38 -5.57 -6.43

Competitive Comparison of Intelgenx Technologies's EV-to-FCF

For the Biotechnology subindustry, Intelgenx Technologies's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intelgenx Technologies's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Intelgenx Technologies's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Intelgenx Technologies's EV-to-FCF falls into.



Intelgenx Technologies EV-to-FCF Calculation

Intelgenx Technologies's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=41.482/-6.677
=-6.21

Intelgenx Technologies's current Enterprise Value is €41.48 Mil.
Intelgenx Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-6.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Intelgenx Technologies  (FRA:0IL) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Intelgenx Technologies's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.143/-0.054
=At Loss

Intelgenx Technologies's share price for today is €0.143.
Intelgenx Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.054.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Intelgenx Technologies EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Intelgenx Technologies's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Intelgenx Technologies (FRA:0IL) Business Description

Traded in Other Exchanges
Address
6420 Abrams, Ville Saint Laurent, QC, CAN, H4S 1Y2
Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilmTM technology platform. Intelegenx focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers a comprehensive portfolio of pharmaceutical services, including pharmaceutical R&D, clinical monitoring, regulatory support, tech transfer and manufacturing scale-up, and commercial manufacturing. Its geographical segments are Europe, Canada, and United States.

Intelgenx Technologies (FRA:0IL) Headlines

No Headlines